Platform
Our Platform
Computational Biology
Infrastructure to analyze complex molecular and clinical data derived from samples from patients with autoimmune diseases, using an artificial intelligence framework
Dimitra Chalkia, PhD
VICE PRESIDENT, COMPUTATIONAL BIOLOGY
June Guo, PhD
DIRECTOR, MACHINE LEARNING & DATA ENGINEERING
Medicinal Chemistry
Infrastructure to design and synthesize new chemical drug compounds against gene targets identified by our computational platform
David Ho, PhD
VICE PRESIDENT, MEDICINAL CHEMISTRY
Analytical Chemistry
Perform quality control analysis, including absorption, delivery and solubility of the drug compounds developed by the medicinal chemistry team
Phithi Nguyen
VICE PRESIDENT, ANALYTICAL CHEMISTRY
Nalin Singh, PhD
RESEARCH SCIENTIST, ANALYTICAL CHEMISTRY
Operations
Supporting day to day business operations, including finance, human resources and lab management.
Jodi Pantuck
CHIEF OF STAFF & OPERATIONS
Jonathan Abdala
MANAGER, OPERATIONS
Cellular & Animal Studies
Evaluate the safety and efficacy profile of novel drug compounds in cellular and animal models of autoimmune diseases and cancer.
Iordanis Karagiannidis, PhD
CHIEF SCIENTIFIC OFFICER
Malvina Tsamouri, DVM, PhD
SENIOR SCIENTIST, ANIMAL STUDIES
George Dialynas, PhD
Director, Human Bioassays